Lophora
PrivateLast Round
VC Round
Jan 15, 2025
Total Funding Raised
$2.2M
Company Overview
Lophora is a clinical-stage CNS therapeutics company developing differentiated, next-generation neuroactive medicines designed to induce neuroplasticity and address significant unmet needs in neuropsychiatry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lophora Comparables
Compare Lophora with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delix Therapeutics | 89% | |
| Xylo Bio | 83% | |
| Reunion Neuroscience Inc. | 83% | |
Lophora Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 15, 2025 | ||||
| VC Round | Aug 24, 2023 | ||||
| VC Round | Mar 2, 2021 | ||||
| Grant | Mar 2, 2021 | ||||
| Convertible Debt | Apr 3, 2020 |
Key People
Founding team and executive leadership
Lophora Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Novo Nordisk Foundation | Convertible Debt |
| The Export and Investment Fund of Denmark | VC Round |
| BioInnovation Institute | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors grew 247% MoM, from 420 to 1.5K.
- Jan 14, 2025
Monthly visitors grew 247% MoM to 594.
Lophora Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lophora's valuation, stock price, and market status.